Showing results (321-330 of 1,683) with videos related to

Sort By:
Pageof 169
Nuclear Medicine Communications|October 19, 2001
Reproducibility of [11 C]FLB 457 binding in extrastriatal regionsY Sudo, T Suhara, M Inoue, et al.
Psychopharmacology|August 6, 2000
High 5HT2A receptor occupancy in M100907-treated schizophrenic patientsM Talvik-Lotfi, S Nyberg, A L Nordström, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazineC Härnryd, L Bjerkenstedt, K Björk, et al.
Schizophrenia Bulletin|January 1, 1988
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatumN C Andreasen, R Carson, M Diksic, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1997
Tyrosine hydroxylase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholicsT Geijer, E Jönsson, J Neiman, et al.
Synapse (New York, N.Y.)|March 12, 2010
Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brainS J Finnema, A Varrone, T J Hwang, et al.
Nuclear Medicine and Biology|May 27, 2014
A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAMF Gourand, P Emond, J P Bergström, et al.
Neurology|April 6, 2000
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's diseaseV Kaasinen, K Någren, J Hietala, et al.
Translational Psychiatry|January 9, 2014
A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaquesH Yamanaka, C Yokoyama, H Mizuma, et al.
Nuclear Medicine and Biology|August 1, 1996
11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PETC Foged, C Halldin, C Loc'h, et al.
Pageof 169